PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11017881-4	2000	Inhibition of cytoplasmic dynein based motility by overexpression of the dynactin subunit, dynamitin (p50), inhibited the movement of peroxisomes in vivo and interfered with the reestablishment of a uniform distribution of peroxisomes after recovery from nocodazole treatment.	Nocodazole	255-265	nuclear factor kappa B subunit 1	Homo sapiens	102-105	
21060745-4	2010	Interestingly pretreatment of microtubule disrupting agents (colchicine, vinblastine and nocodazole) was observed to lead to paradoxical suppression of DNA damage-induced NF-kappaB binding activity, even though these could enhance NF-kappaB signaling in the absence of other stimuli.	Nocodazole	89-99	nuclear factor kappa B subunit 1	Homo sapiens	171-180	
21060745-4	2010	Interestingly pretreatment of microtubule disrupting agents (colchicine, vinblastine and nocodazole) was observed to lead to paradoxical suppression of DNA damage-induced NF-kappaB binding activity, even though these could enhance NF-kappaB signaling in the absence of other stimuli.	Nocodazole	89-99	nuclear factor kappa B subunit 1	Homo sapiens	231-240	
12121873-8	2002	Inhibition of tubulin polymerization with nocodazole causes NF-kappaB/Rel activation in pancreatic lobules.	Nocodazole	42-52	nuclear factor kappa B subunit 1	Homo sapiens	60-69	
11817569-3	2001	In 2B4 cells, nocodazole had no effect on the activity of NF-kappaB, but in CHO-K1 and HeLa cells it caused a transient decrease, sometimes followed by an increase in the content of subunit p50.	Nocodazole	14-24	nuclear factor kappa B subunit 1	Homo sapiens	190-193